位置:成果数据库 > 期刊 > 期刊详情页
氨甲蝶呤对映体耐药A549细胞株的建立及其生物学特征
  • ISSN号:1000-8578
  • 期刊名称:肿瘤防治研究
  • 时间:0
  • 页码:273-277
  • 语言:中文
  • 分类:R734.2[医药卫生—肿瘤;医药卫生—临床医学] R73-3[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]安徽医科大学附属省立医院安徽省临床检验中心,合肥230001, [2]安徽医科大学附属省立医院血液科,合肥230001
  • 相关基金:国家自然科学基金项目(30672011);安徽省自然科学基金资助项目(050430902);安徽省人才开发资金资助项目(2005Z040)
  • 相关项目:MTX对映体诱导肺癌A549细胞获得性耐药机制研究
中文摘要:

目的诱导并建立耐氨甲蝶呤对映体的A549细胞株并观察耐药细胞系(L-(+)-MTX/A549、D-(-)-MTX/A549)的生物学特性。方法以MTX对映体为诱导剂,采用浓度递增结合低剂量持续诱导方法诱导A549细胞株,建立MTX不同对映体耐药细胞系;倒置相差显微镜观察细胞形态变化;MTT法绘制细胞生长曲线;MTT法检测耐药细胞株的耐药指数;流式细胞仪检测细胞周期和细胞的分裂增殖能力。结果L-(+)MTX/A549、D-(-)MTX/A549耐药指数分别为6.0的和20.2。倒置相差显微镜观察细胞形态发生了改变;细胞生长曲线显示D-(-)-MTX/A549的增殖略慢于亲本细胞,而L-(+)-MTX/A549的增殖最慢;流式细胞仪检测细胞周期结果显示L-(+)MTX/A549、D-(-)-MTX/A549耐药细胞株S期细胞数量减少(P〈0.05),G0/G1期细胞增多(P〈0.05);CFSE检测A549、L-(+)-MTX/A549、D-(-)-MTX/A549的MFI分别为(6.08±0.55)、(7.72±0.30)、(6.90±0.18)。两对映体细胞株间有明显手性差异。结论本研究建立了MTX两种对映体耐药细胞株,为进一步研究其耐药机制提供了一种实验模型。

英文摘要:

Objective To establish methotrexate(MTX) enantiomers resistant human NSCCL A549 cell line ( L( + )-MTX/A549,D( - )-MTX/A549) derived from the A549 cell line and observe its biological characters. Methods A549 cells were exposed to intermittently and progressively increasing doses of MTX enantiomers. Two MTX enantiomers (L and D) resistant human NSCLC A549 cell lines were established. The morphology was observed by inverted phase contrast microscope, the sensitivity of the L- ( + )-MTX/A549, D-( - ) MTX/A549 cell lines to MTX enantiomers was measured by cytotoxicity test. The cell growth curve was determined by MTT assay, the change of CFSE fluorescence intensity and cell cycle distribution were analyzed by flow cytometry assay. Results The L( + )-MTX/A549 resistance index was 6. 0 and D-( - )-MTX/A549 resistance index was 20. 2. Inverted phase contrast microscope showed morphological changes of L-( + )-MTX/A549 and D-( - )-MTX/A549. Cell growth curve demonstrated that the proliferation abilities of L-( + ) MTX/A549 was decreased significantly, while the cell proliferation rate of D-( - )-MTX/A549 was similar to that of A549. The flow cytometry results showed L-( + )-MTX/A549 and D-( - ) MTX/A549 cells at S phase were reduced (P〈0. 05) , with an increased at G0/G1 phase (P〈0. 05), the CFSE mean fluorescence intensity of A549 parent cells, L( + )- MTX/A549 and D-( - )-MTX/A549 were (6. 08 ±0. 55), (7. 72 ±0. 30), (6. 90 ± 0. 18). Two enantiomers resistance cell lines have a clear difference in Chirality. Conclusion We established two MTX enantiomers resistant human A549 cell lines and observed their different biological characteristics. It provides a new experimental model for further studying the mechanism of MTX enantiomers resistance.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《肿瘤防治研究》
  • 中国科技核心期刊
  • 主管单位:中华人民共和国卫生部
  • 主办单位:湖北省卫生厅 中国抗癌协会 湖北省肿瘤医院
  • 主编:魏少忠
  • 地址:武昌卓刀泉南路116号
  • 邮编:430079
  • 邮箱:zlfzyj@263.net.cn
  • 电话:027-87670126
  • 国际标准刊号:ISSN:1000-8578
  • 国内统一刊号:ISSN:42-1241/R
  • 邮发代号:38-70
  • 获奖情况:
  • 中国学术期刊综合评价数据库来源期刊,中国科学引文数据库来源期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),英国农业与生物科学研究中心文摘,波兰哥白尼索引,美国剑桥科学文摘,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版)
  • 被引量:17449